Erschienen in:
01.08.2014 | Colorectal Cancer
Nuclear Notch3 Expression is Associated with Tumor Recurrence in Patients with Stage II and III Colorectal Cancer
verfasst von:
Tsuyoshi Ozawa, MD, Shinsuke Kazama, MD, PhD, Takashi Akiyoshi, MD, PhD, Koji Murono, MD, Satomi Yoneyama, MD, PhD, Toshiaki Tanaka, MD, PhD, Junichiro Tanaka, MD, PhD, Tomomichi Kiyomatsu, MD, PhD, Kazushige Kawai, MD, PhD, Hiroaki Nozawa, MD, PhD, Takamitsu Kanazawa, MD, PhD, Hironori Yamaguchi, MD, PhD, Soichiro Ishihara, MD, PhD, Eiji Sunami, MD, PhD, Joji Kitayama, MD, PhD, Teppei Morikawa, MD, PhD, Masashi Fukayama, MD, PhD, Toshiaki Watanabe, MD, PhD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 8/2014
Einloggen, um Zugang zu erhalten
Abstract
Background
The importance of Notch signaling in colorectal cancer (CRC) tumorigenesis has been recently recognized. However, the significance of Notch3 expression and its association with Notch1 expression in CRC is unclear. In the present study, we investigated Notch1 and Notch3 expression in Stage II and III CRC to assess their association with clinicopathological characteristics.
Methods
The protein expression of Notch1 and Notch3 was examined using immunohistochemistry in 305 CRC specimens. Nuclear expression of Notch1 and Notch3 and their associations with clinicopathological characteristics and distant relapse-free survival (dRFS) were evaluated.
Results
Nuclear Notch1 was overexpressed in 37 % of specimen, and nuclear Notch3 in 38 %. Nuclear Notch3 expression correlated with tumor differentiation status (P = 0.0099). Nuclear expression of Notch1 and Notch3 was associated with tumor recurrence (P = 0.0311 and P = 0.0053, respectively). In multivariate analysis, nuclear Notch3 expression [hazard ratio (HR) = 1.71; 95 % confidence interval (CI), 1.06–2.78; P = 0.0271), lymph node metastasis, and venous involvement were independently correlated with dRFS. In subgroup analysis, nuclear Notch3 expression was strongly associated with dRFS in Stage II CRC (HR = 3.47; 95 % CI 1.44–9.22; P = 0.0055). Both nuclear Notch1 and Notch3 were positive in 67 specimens (22 %) and both were negative in 144 specimens (47 %). Coexpression of nuclear Notch1 and Notch3 had an additive effect toward poorer dRFS compared with a negative subtype (HR = 2.48; 95 % CI, 1.41–4.40; P = 0.0019).
Conclusions
Nuclear Notch3 expression might be a novel predictive marker for recurrence in Stage II and III CRC.